Insight Molecular Diagnostics Inc share price logo

Insight Molecular Diagnostics Inc Share Price

NASDAQ: IMDX

Small Cap

$3.94

-0.06

(-1.50%)

as on

Insight Molecular Diagnostics Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.44
    $4.11
    downward going graph

    12.69%

    Downside

    4.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.33
    $8.51
    downward going graph

    40.86%

    Downside

    115.99%

    Upside

    downward going graph

Insight Molecular Diagnostics Inc share price movements today

Previous Close
$4.00
Open
$4.00
Volume
570.3K
Day's Low - High
$3.44 - $4.11
52 Week Low - High
$2.33 - $8.51

Insight Molecular Diagnostics Inc Historical Returns

1 Month Return
-30.43 %
3 Month Return
-31.27 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Insight Molecular Diagnostics Inc Stock Fundamentals & Key Indicators

Check Insight Molecular Diagnostics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$122.2M

EPS (TTM)

-1.15

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-23603.11%

Insight Molecular Diagnostics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Insight Molecular Diagnostics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Insight Molecular Diagnostics Inc image
Insight Molecular Diagnostics Inc
NA$122.2MNANA0.00%
Idexx Laboratories, Inc. image
Idexx Laboratories, Inc.
BUY$46.1B22.54%44.0724.62%
Waters Corporation image
Waters Corporation
HOLD$29.6B10.55%28.0520.30%
Thermo Fisher Scientific, Inc. image
Thermo Fisher Scientific, Inc.
BUY$176.2B8.1%26.7415.05%
Agilent Technologies Inc. image
Agilent Technologies Inc.
BUY$31.7B-8.11%24.7318.26%
See all

Insight Molecular Diagnostics Inc Stock’s Investor Sentiment and Interest

Search interest for Insight Molecular Diagnostics Inc Stock has decreased by -78% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-78% versus previous 30 day period

Insight Molecular Diagnostics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
0
0
0
1
2
0
0
Gross Profit
0
0
0
0
0
0
0
1
0
0
Operating Income
5
-8
-6
-9
-4
-13
-33
-6
-9
-11
EBITDA
6
-7
-6
-8
-4
-13
-32
-6
-9
-10
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
0
0
0
0
0
0
0
Income Before Tax
5
-8
-6
-9
-4
-13
-33
-6
-9
-10
Income Tax Expense
2
4
0
8
-
-
-
-
-
-
Net Income
3
-8
-6
-9
-4
-13
-33
-6
-9
-10
Net Profit Margin
1021.21%
-1799.78%
-1512.59%
-5186.93%
-4355.77%
-11733.04%
-2255.11%
-312.02%
-1880.69%
-4174.62%

Insight Molecular Diagnostics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
2
0
1
1
Gross Profit
0
1
0
0
0
Operating Income
-29
-53
-17
-25
-61
EBITDA
-30
-48
-13
-23
-59
Interest Expense
0
0
0
0
0
Depreciation
-
4
5
1
1
Income Before Tax
-31
-52
-18
-24
-60
Income Tax Expense
-1
-9
54
-
-
Net Income
-29
-64
-72
-27
-60
Net Profit Margin
-2461.51%
-2916.15%
-7609.81%
-1848.37%
-3225.04%

Insight Molecular Diagnostics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-8
-6
-9
-4
-13
-33
-6
-9
-10
Operating Cash Flow
-6
-2
-3
-5
-5
-5
-5
-6
-4
Investing Cash Flow
0
-1
0
0
0
0
0
0
-1
Financing Cash Flow
12
0
0
9
0
10
28
0
0
Change in Cash
5
-3
-3
3
-5
5
22
-6
-5

Insight Molecular Diagnostics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-11
-19
-15
-22
-29
-64
-72
-27
-60
Operating Cash Flow
-7
-13
-11
-19
-25
-35
-45
-23
-20
Investing Cash Flow
0
0
0
-12
-11
-13
-4
0
0
Financing Cash Flow
9
9
12
47
22
78
35
12
20
Change in Cash
2
-2
0
15
-14
28
-14
-12
0

Insights on Insight Molecular Diagnostics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Idexx Laboratories, Inc. has given 38.5% return, outperforming this stock by 6.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Idexx Laboratories, Inc. has given 19.2% return, outperforming this stock by 42.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 2.13M → 260.0K (in $), with an average decrease of 62.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -6.67M → -10.85M (in $), with an average decrease of 28.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IMDX stock has moved down by -8.7%

About Insight Molecular Diagnostics Inc

Insight Molecular Diagnostics Inc., formerly Oncocyte Corporation, is a molecular diagnostics technology company. The Company's technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is in the process of rebranding its VitaGraft assay (also known as VitaGraft Kidney), which is a lab developed test, under the name GraftAssureCore. The Company's transplant products include GraftAssureCore, GraftAssureDx, GraftAssureIQ. Its oncology products include DetermaCNI, DetermaIO, and OncoTIME. GraftAssureCore is a clinical blood-based solid organ transplantation monitoring test. GraftAssureIQ is a research use only (RUO) blood-based solid organ transplantation monitoring test. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaCNI is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. OncoTIME enables research on the tumor immune microenvironment.
OrganisationInsight Molecular Diagnostics Inc
Headquarters2 International Plaza Dr., Nashville, TN, United States, 37217
CEOMr. Joshua Riggs
E-voting on sharesClick here to vote

Key Management of Insight Molecular Diagnostics Inc

Name

Title

Mr. Joshua Riggs

President, CEO & Director

Mr. Steven Tahmooressi

Vice President of Marketing

Ms. Sandra O'Donald

Senior Vice President of Business Operations

Dr. Michael D. West Ph.D.

Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.

Ms. Andrea Susan James

Chief Financial Officer

Mr. James Liu

VP of Accounting, Treasurer, Controller & Principal Accounting Officer

Dr. Ekkehard Schutz M.D., Ph.D.

Chief Science Officer

Mr. Yuh-Min Chiang Ph.D.

Chief Technology Officer

Mr. Peter Hong

VP, General Counsel & Secretary

Dr. Paul R. Billings FACP, M.D., Ph.D.

Consulting Chief Medical Officer

FAQs

What is Insight Molecular Diagnostics Inc share price today?

Insight Molecular Diagnostics Inc share price today is $3.94 as on at the close of the market. Insight Molecular Diagnostics Inc share today touched a day high of $4.11 and a low of $3.44.

What is the 52 week high and 52 week low for Insight Molecular Diagnostics Inc share?

Insight Molecular Diagnostics Inc share touched a 52 week high of $8.51 on and a 52 week low of $2.33 on . Insight Molecular Diagnostics Inc stock price today i.e. is closed at $3.94,which is 53.70% down from its 52 week high and 69.10% up from its 52 week low.

What is Insight Molecular Diagnostics Inc's market capitalisation today?

Insight Molecular Diagnostics Inc market capitalisation is $0.00T as on .

How to invest in Insight Molecular Diagnostics Inc Stock (IMDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Insight Molecular Diagnostics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Insight Molecular Diagnostics Inc Shares that will get you 0.3807 shares as per Insight Molecular Diagnostics Inc share price of $3.94 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Insight Molecular Diagnostics Inc Stock (IMDX) from India?

Indian investors can start investing in Insight Molecular Diagnostics Inc (IMDX) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Insight Molecular Diagnostics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Insight Molecular Diagnostics Inc share’s latest price of $3.94 as on March 25, 2026 at 1:29 am IST, you will get 2.5381 shares of Insight Molecular Diagnostics Inc. Learn more about fractional shares .